AArkstore enterprise 17th Novenber 2014
Portal Hypertension Ther apeutics - Pipeline Assessment and Market Browse Full Report @ http://www.aarkstore.com/pharmaceuticals-healthcare/60327/portal-hypertensiontherapeutics-pipeline-assessment-and-market-forecasts Published: Feb 2012 | No. Of Pages: 57 Pages PDF: $ 3995 | Site Licence : $ 7990 | Enterprise Wide Licence : $ 11985
Forecasts to 2019
Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Summary the industry analysis specialist, has released its new report, Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of information and analysis on the global Portal Hypertension Therapeutics market. The report identifies the key trends shaping and driving the global
Website : http://www.aarkstore.com/
AArkstore enterprise Portal Hypertension Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Portal Hypertension Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
Scope The report provides information on the key drivers and challenges of the Portal Hypertension Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Portal Hypertension Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Portal Hypertension Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Portal Hypertension Therapeutics market. - Analysis of key recent licensing and partnership agreements in Portal Hypertension Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
Website : http://www.aarkstore.com/
AArkstore enterprise - Develop business strategies by understanding the trends shaping and driving the global Portal Hypertension Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Portal Hypertension Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - Whats the next big thing in the global Portal Hypertension Therapeutics market landscape? Identify, understand and capitalize.
Special Discount on Market Research Reports: Click here for Best Discount offer on every market research reports: Offer valid till 31st December 2014 http://www.aarkstore.com/discount.php
Tables Of Contents 2 Portal Hypertension Cirrhosis Therapeutics - Introduction 6 2.1 Overview 6 2.2 Portal Venous System 6 2.3 Pathophysiology 7 2.4 Epidemiology 8 2.5 Causes 8 2.6 Child-Pugh Classification of Cirrhosis 10
Website : http://www.aarkstore.com/
AArkstore enterprise 2.7 Symptoms 11 2.8 Diagnosis 11 2.9 Treatment 12 2.9.1 Variceal hemorrhage 12 2.9.2 Ascites 14 2.10 GlobalData Pipeline Report Guidance 15 3 Portal Hypertension Therapeutics - Market Characterization 16 3.1 Portal Hypertension Therapeutics Market Size (2006-2011) - Global 16 3.2 Portal Hypertension Therapeutics Market Forecast (2011-2019) - Global 17 3.3 Portal Hypertension Therapeutics Market Size (2006-2011) - The US 18 3.4 Portal Hypertension Therapeutics Market Forecast (2011-2019) - The US 19 3.5 Portal Hypertension Therapeutics Market Size (2006-2011) - France 20 3.6 Portal Hypertension Therapeutics Market Forecast (2011-2019) - France 21 3.7 Portal Hypertension Therapeutics Market Size (2006-2011) - Germany 22 3.8 Portal Hypertension Therapeutics Market Forecast (2011-2019) -Germany 23 3.9 Portal Hypertension Therapeutics Market Size (2006-2011) - Italy 24 3.10 Portal Hypertension Therapeutics Market Forecast (2011-2019) - Italy 25 3.11 Portal Hypertension Therapeutics Market Size (2006-2011) - Spain 26 3.12 Portal Hypertension Therapeutics Market Forecast (2011-2019) - Spain 27 3.13 Portal Hypertension Therapeutics Market Size (2006-2011) - The UK 28 3.14 Portal Hypertension Therapeutics Market Forecast (2011-2019) - The UK 29 3.15 Portal Hypertension Therapeutics Market Size (2006-2011) - Japan 30 3.16 Portal Hypertension Therapeutics Market Forecast (2011-2019) - Japan 31
Website : http://www.aarkstore.com/
AArkstore enterprise 3.17 Drivers and Barriers 32 3.17.1 Drivers for the Portal Hypertension Therapeutics Market 32 3.17.2 Barriers for the Portal Hypertension Therapeutics Market 32 3.18 Opportunity and Unmet Need Analysis 33 3.19 Key Takeaway 34 4 Portal Hypertension Therapeutics - Competitive Assessment 35 4.1 Overview 35 4.1.1 Strategic Competitor Assessment 35 4.2 Product Profile for the Major Marketed Products in the Portal Hypertension Therapeutics Market 36 4.2.1 Beta-Blockers 36 4.2.2 Vasopressin and its Analogs 36 4.2.3 Somatostatin and its Analogs 36 4.3 Key Takeaway 36 5 Portal Hypertension Therapeutics - Pipeline Assessment 37 5.1 Overview 37 5.2 Strategic Pipeline Assessment 37 5.3 Portal Hypertension Therapeutics Pipeline - Pipeline by Clinical Phase of Development 37 5.4 Pipeline Analysis by Phase of Development 38 5.4.1 Portal Hypertension Therapeutics - Phase II/III Pipeline 38 5.4.2 Portal Hypertension Therapeutics - Phase II Pipeline 38 5.5 Technology Trends Analytical Framework 38 5.6 Pipeline by Mechanism of Action 39 5.7 Profiles of Key Late Stage Pipeline Drugs 40
Website : http://www.aarkstore.com/
AArkstore enterprise 5.7.1 Octreolin (octreotide) 40 5.7.2 Sapropterin (tetrahydrobiopterin) 40 5.7.3 Udenafil (DA-8519) 40 5.8 Key Takeaway 41 6 Portal Hypertension Therapeutics - Clinical Trials Mapping 42 6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 42 6.2 Clinical Trials by Phase 43 6.3 Clinical Trials by Trial Status 44 6.4 Overall Sponsors 45 6.5 Prominent Sponsors 46 6.6 Companies Participating in Therapeutics Clinical Trials 47 7 Portal Hypertension Therapeutics - Strategic Assessment 48 7.1 Portal Hypertension Therapeutics - Implications for Future Market Competition 48 8 Portal Hypertension Therapeutics - Future Players 49 8.1 Introduction 49 8.2 Company Profile 49 8.2.1 Chiasma (Israel) Ltd. 49 8.2.2 Dong-A Pharmaceutical Co Ltd (Dong-A) 50 9 Portal Hypertension Therapeutics - Deals 51 10 Portal Hypertension Therapeutics - Appendix 52 10.1 Market Definitions 52 10.2 Abbreviation 52 10.3 Methodology 53
Website : http://www.aarkstore.com/
AArkstore enterprise 10.3.1 Coverage 53 10.3.2 Secondary Research 53 10.3.3 Forecasting 54 10.3.4 Primary Research 56 10.3.5 Expert Panel Validation 56 10.4 Contact Us 56 10.5 Disclaimer 56 10.6 Sources 57
List Of Tables Table 1: Child-Pugh Classification of Cirrhosis 10 Table 2: Status Classification of Cirrhosis 11 Table 3: Portal Hypertension Therapeutics Market, Global, Revenue ($bn), 2006-2011 16 Table 4: Portal Hypertension Therapeutics Market, Global, Forecast ($bn), 2011-2019 17 Table 5: Portal Hypertension Therapeutics Market, the US, Revenue ($m), 2006-2011 18 Table 6: Portal Hypertension Therapeutics Market, the US, Forecast ($m), 2011-2019 19 Table 7: Portal Hypertension Therapeutics Market, France, Revenue ($m), 2006-2011 20 Table 8: Portal Hypertension Therapeutics Market, France, Forecast ($m), 2011-2019 21 Table 9: Portal Hypertension Therapeutics Market, Germany, Revenue ($m), 2006-2011 22 Table 10: Portal Hypertension Therapeutics Market, Germany, Forecast ($m), 2011-2019 23 Table 11: Portal Hypertension Therapeutics Market, Italy, Revenue ($m), 2006-2011 24 Table 12: Portal Hypertension Therapeutics Market, Italy, Forecast ($m), 2011-2019 25 Table 13: Portal Hypertension Therapeutics Market, Spain, Revenue ($m), 2006-2011 26
Website : http://www.aarkstore.com/
AArkstore enterprise Table 14: Portal Hypertension Therapeutics Market, Spain, Forecast ($m), 2011-2019 27 Table 15: Portal Hypertension Therapeutics Market, the UK, Revenue ($m), 2006-2011 28 Table 16: Portal Hypertension Therapeutics Market, the UK, Forecast ($m), 2011-2019 29 Table 17: Portal Hypertension Therapeutics Market, Japan, Revenue ($m), 2006-2011 30 Table 18: Portal Hypertension Therapeutics Market, Japan, Forecast ($m), 2011-2019 31 Table 19: Portal Hypertension Therapeutics - Phase II/III Pipeline, 2011 38 Table 20: Portal Hypertension Therapeutics - Phase II Pipeline, 2011 38 Table 21: Portal Hypertension Therapeutics - Clinical Trials by Country, 2011 42 Table 22: Portal Hypertension Therapeutics - Clinical Trials by Phase, 2011 43 Table 23: Portal Hypertension Therapeutics - Clinical Trials by Status, 2011 44 Table 24: Portal Hypertension Therapeutics - Overall Sponsors, 2011 45 Table 25: Portal Hypertension Therapeutics - Prominent Sponsors, 2011 46 Table 26: Portal Hypertension Therapeutics - Company Participating in Therapeutics Clinical Trials, 2011 47 Table 27: Portal Hypertension Therapeutics - Pipeline by Company, 2011 49 Table 28: Chiasma (Israel) - Portal Hypertension Therapeutics Pipeline 49 Table 29: Dong-A Pharmaceutical Co., Ltd. - Portal Hypertension Therapeutics Pipeline 50 Table 30: Portal Hypertension Therapeutics, Global, Deals, 2011 51
List Of Figures Figure 1: Portal Venous System 6 Figure 2: Portal Hypertension: Pathophysiology 8 Figure 3: Portal Hypertension: Prehepatic Causes 9 Figure 4: Portal Hypertension: Hepatic Causes 9
Website : http://www.aarkstore.com/
AArkstore enterprise Figure 5: Portal Hypertension: Posthepatic Causes 10 Figure 6: Transjugular Intrahepatic Portosystemic Shunt (TIPS) 13 Figure 7: Portal Hypertension Therapeutics Market, Global, Revenue ($bn), 2006-2011 16 Figure 8: Portal Hypertension Therapeutics Market, Global, Forecast ($bn), 2011-2019 17 Figure 9: Portal Hypertension Therapeutics Market, the US, Revenue ($m), 2006-2011 18 Figure 10: Portal Hypertension Therapeutics Market, the US, Forecast ($m), 2011-2019 19 Figure 11: Portal Hypertension Therapeutics Market, France, Revenue ($m), 2006-2011 20 Figure 12: Portal Hypertension Therapeutics Market, France, Forecast ($m), 2011-2019 21 Figure 13: Portal Hypertension Therapeutics Market, Germany, Revenue ($m), 2006-2011 22 Figure 14: Portal Hypertension Therapeutics Market, Germany, Forecast ($m), 2011-2019 23 Figure 15: Portal Hypertension Therapeutics Market, Italy, Revenue ($m), 2006-2011 24 Figure 16: Portal Hypertension Therapeutics Market, Italy, Forecast ($m), 2011-2019 25 Figure 17: Portal Hypertension Therapeutics Market, Spain, Revenue ($m), 2006-2011 26 Figure 18: Portal Hypertension Therapeutics Market, Spain, Forecast ($m), 2011-2019 27 Figure 19: Portal Hypertension Therapeutics Market, the UK, Revenue ($m), 2006-2011 28 Figure 20: Portal Hypertension Therapeutics Market, the UK, Forecast ($m), 2011-2019 29 Figure 21: Portal Hypertension Therapeutics Market, Japan, Revenue ($m), 2006-2011 30 Figure 22: Portal Hypertension Therapeutics Market, Japan, Forecast ($m), 2011-2019 31 Figure 23: Portal Hypertension Therapeutics, Drivers and Restraints, 2011 33 Figure 24: Opportunity and Unmet Need in the Portal Hypertension Therapeutics Market, 2011 34 Figure 25: Portal Hypertension Therapeutics - Strategic Competitor Assessment, 2011 35 Figure 26: Portal Hypertension Therapeutics - Pipeline by Phase of Clinical Development, 2011 37 Figure 27: Portal Hypertension Therapeutics - Technology Trends Analytics Framework, 2011 38
Website : http://www.aarkstore.com/
AArkstore enterprise Figure 28: Portal Hypertension Therapeutics - Technology Trends Analytics Framework - Description, 2011 39 Figure 29: Portal Hypertension Therapeutics - Mechanism of Action, 2011 39 Figure 30: Portal Hypertension Therapeutics - Clinical Trials by Country, 2011 42 Figure 31: Portal Hypertension Therapeutics - Clinical Trials by Phase, 2011 43 Figure 32: Portal Hypertension Therapeutics - Clinical Trials by Status, 2011 44 Figure 33: Portal Hypertension Therapeutics - Overall Sponsors, 2011 45 Figure 34: Portal Hypertension Therapeutics - Prominent Sponsors, 2011 46 Figure 35: Portal Hypertension Therapeutics - Company Participating in Therapeutics Clinical Trials, 2011 47 Figure 36: Portal Hypertension Therapeutics - Implications for Future Market Competition, 2011 48 Figure 37: GlobalData Market Forecasting Model 55
Related reports: Polycystic Kidney Disease (PKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Social Anxiety Disorders (SAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Psychotic Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Panic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Tourette Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Website : http://www.aarkstore.com/
AArkstore enterprise Infantile Spasms Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hunter Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Myelofibrosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
About Aarkstore Enterprise Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.
You can order full Report with TOC and Sample page visit: http://www.aarkstore.com/pharmaceuticals-healthcare/60327/portalhypertension-therapeutics-pipeline-assessment-and-market-forecasts
Contact Details: Aarkstore Enterprise Phone: +91 998 729 5242 Email: enquiry@aarkstore.com Our Website: http://www.aarkstore.com
Website : http://www.aarkstore.com/
AArkstore enterprise Facebook: https://www.facebook.com/aarkstoredotcom Linkedin: http://www.linkedin.com/company/aarkstore-enterprise
Website : http://www.aarkstore.com/